{"id":"W2803637134","doi":"10.1212/wnl.88.16_supplement.s27.002","title":"Oral Fingolimod in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (FORCIDP): Results from a Phase III Randomized Placebo-controlled Trial (S27.002)","year":2017,"lang":"en","type":"article","venue":"Neurology","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Polyradiculoneuropathy; Medicine; Placebo; Fingolimod; Randomized controlled trial; Internal medicine; Multiple sclerosis; Immunology; Guillain-Barre syndrome; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001314753,0.0004389007,0.002115814,0.0002358283,0.0003594284,0.00007576446,0.0004332078,0.0003278897,0.0001171239],"category_scores_gemma":[0.005689002,0.0003662819,0.0004792416,0.00008933417,0.0004884246,0.0001911666,0.0002050542,0.001033823,0.00003292737],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006506211,"about_ca_system_score_gemma":0.0003791933,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001687982,"about_ca_topic_score_gemma":0.001454117,"domain_scores_codex":[0.9955957,0.001001362,0.001386901,0.0008635012,0.0003386906,0.0008138813],"domain_scores_gemma":[0.9966856,0.00111756,0.0008724495,0.001030975,0.00006694544,0.0002264573],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9901975,0.0003310743,0.0001279563,0.0000159285,0.00007944513,0.001410508,0.000392927,0.0001160437,0.003358201,0.0000731226,0.0001810437,0.003716282],"study_design_scores_gemma":[0.957941,0.003531215,0.0007351136,0.00003535312,0.0001884446,0.00004734046,0.00001185707,0.03454315,0.00007176535,0.0002322693,0.002404833,0.0002576772],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9885338,0.0003423835,0.00003815268,0.003491516,0.001430182,0.003955903,0.00002972545,0.0001375191,0.002040822],"genre_scores_gemma":[0.9953839,0.0002436415,0.00003695396,0.00275465,0.0008614674,0.0004193278,0.00004283931,0.00006720929,0.0001900701],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03442711,"threshold_uncertainty_score":0.9998789,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01619745665871437,"score_gpt":0.2933344788653948,"score_spread":0.2771370222066804,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}